BR9609738A - Composições para aplicação de droga para estabilidade melhorada de esteróides - Google Patents
Composições para aplicação de droga para estabilidade melhorada de esteróidesInfo
- Publication number
- BR9609738A BR9609738A BR9609738A BR9609738A BR9609738A BR 9609738 A BR9609738 A BR 9609738A BR 9609738 A BR9609738 A BR 9609738A BR 9609738 A BR9609738 A BR 9609738A BR 9609738 A BR9609738 A BR 9609738A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- drug application
- stability
- improved
- improved steroid
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/504,430 US5780050A (en) | 1995-07-20 | 1995-07-20 | Drug delivery compositions for improved stability of steroids |
| PCT/US1996/010711 WO1997003629A1 (en) | 1995-07-20 | 1996-06-21 | Drug delivery compositions for improved stability of steroids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR9609738A true BR9609738A (pt) | 1999-03-16 |
| BR9609738B1 BR9609738B1 (pt) | 2009-05-05 |
Family
ID=24006230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9609738-8A BR9609738B1 (pt) | 1995-07-20 | 1996-06-21 | dispositivo estabilizado de emplasto para aplicação de uma droga esteróide. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5780050A (pt) |
| EP (2) | EP2305195B1 (pt) |
| JP (2) | JP3422796B2 (pt) |
| KR (1) | KR100505171B1 (pt) |
| CN (2) | CN100446769C (pt) |
| AU (1) | AU710760B2 (pt) |
| BR (1) | BR9609738B1 (pt) |
| CA (1) | CA2226425C (pt) |
| DK (2) | DK2305195T3 (pt) |
| MX (1) | MX9800545A (pt) |
| WO (1) | WO1997003629A1 (pt) |
| ZA (1) | ZA965607B (pt) |
Families Citing this family (99)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6024974A (en) * | 1995-01-06 | 2000-02-15 | Noven Pharmaceuticals, Inc. | Composition and methods for transdermal delivery of acid labile drugs |
| US5783208A (en) * | 1996-07-19 | 1998-07-21 | Theratech, Inc. | Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| US5980898A (en) | 1996-11-14 | 1999-11-09 | The United States Of America As Represented By The U.S. Army Medical Research & Material Command | Adjuvant for transcutaneous immunization |
| US20060002949A1 (en) | 1996-11-14 | 2006-01-05 | Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. | Transcutaneous immunization without heterologous adjuvant |
| US6797276B1 (en) | 1996-11-14 | 2004-09-28 | The United States Of America As Represented By The Secretary Of The Army | Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
| DE19724200A1 (de) | 1997-06-09 | 1998-12-10 | Basf Ag | Bisiminosubstituierte Phenylverbindungen |
| US20020012694A1 (en) * | 1997-09-17 | 2002-01-31 | Alfred J. Moo-Young | Transdermal administration of ment |
| ES2318233T3 (es) * | 1997-11-10 | 2009-05-01 | Strakan International Limited | Sistemas mejoradores de la penetracion y reductores de la irritacion que comprenden testosterona. |
| US6210705B1 (en) | 1997-12-15 | 2001-04-03 | Noven Pharmaceuticals, Nc. | Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| US20020102291A1 (en) * | 1997-12-15 | 2002-08-01 | Noven Pharmaceuticals, Inc. | Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| GB9803032D0 (en) * | 1998-02-12 | 1998-04-08 | Ethical Pharmaceuticals Uk Lim | Transdermal delivery devices |
| EP0943333A1 (de) * | 1998-03-18 | 1999-09-22 | S.W. Patentverwertungs GmbH | Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen |
| EP1109594B1 (en) | 1998-08-31 | 2004-10-27 | Johnson & Johnson Consumer Companies, Inc. | Electrotransport device comprising blades |
| EP2368575B1 (en) * | 1999-04-08 | 2014-10-01 | Intercell USA, Inc. | Dry formulation for transcutaneous immunization |
| ATE290902T1 (de) | 1999-04-16 | 2005-04-15 | Johnson & Johnson Consumer | Vorrichtung zur iontophoretischen verabreichung von medikamenten mit internen sensoren |
| AU4808000A (en) | 1999-04-28 | 2000-11-10 | Situs Corporation | Drug delivery system |
| US7074747B1 (en) | 1999-07-01 | 2006-07-11 | Johnson & Johnson Consumer Companies, Inc. | Cleansing compositions |
| US6762158B2 (en) | 1999-07-01 | 2004-07-13 | Johnson & Johnson Consumer Companies, Inc. | Personal care compositions comprising liquid ester mixtures |
| AU5764800A (en) | 1999-07-01 | 2001-01-22 | Johnson & Johnson Consumer Companies, Inc. | Cleansing compositions |
| ES2282123T3 (es) | 1999-07-08 | 2007-10-16 | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | Dispositivo de administracion por via topica exomerico. |
| US6890553B1 (en) | 1999-07-08 | 2005-05-10 | Johnson & Johnson Consumer Companies, Inc. | Exothermic topical delivery device |
| US7384650B2 (en) * | 1999-11-24 | 2008-06-10 | Agile Therapeutics, Inc. | Skin permeation enhancement composition for transdermal hormone delivery system |
| EP1132084A1 (en) * | 2000-03-06 | 2001-09-12 | Docteur Nature Srl | Transdermal device for the slow release of soybean derived vegetable estrogens |
| WO2002004570A2 (en) | 2000-07-07 | 2002-01-17 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
| USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| WO2002045701A2 (en) * | 2000-12-05 | 2002-06-13 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
| DE60227157D1 (de) | 2001-02-13 | 2008-07-31 | Us Gov Sec Army | Impstoffe zur transkutanen immunisierung gegen reisediarrhö |
| EP1381381A1 (en) * | 2001-03-19 | 2004-01-21 | Gregory M. Glenn | Patch for transcutaneous immunization |
| US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
| US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
| US20050113510A1 (en) | 2001-05-01 | 2005-05-26 | Feldstein Mikhail M. | Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
| US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
| US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
| JP4116447B2 (ja) | 2001-05-01 | 2008-07-09 | エイ．ブイ．トップチーブ インスティテュート オブ ペトロケミカル シンセシス | ヒドロゲル組成物 |
| AU2002316053A1 (en) | 2001-05-01 | 2002-11-11 | A.V. Topchiev Institute Of Petrochemical Synthesis | Two-phase, water-absorbent bioadhesive composition |
| DK1406633T3 (da) * | 2001-06-18 | 2011-10-31 | Noven Pharma | Forbedret lægemiddeltilførsel i transdermale systemer |
| DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| US20030175329A1 (en) * | 2001-10-04 | 2003-09-18 | Cellegy Pharmaceuticals, Inc. | Semisolid topical hormonal compositions and methods for treatment |
| US7921999B1 (en) | 2001-12-20 | 2011-04-12 | Watson Laboratories, Inc. | Peelable pouch for transdermal patch and method for packaging |
| US20040137004A1 (en) * | 2002-03-19 | 2004-07-15 | Glenn Gregory M | Patch for transcutaneous immunization |
| KR20100055542A (ko) | 2002-06-25 | 2010-05-26 | 애크럭스 디디에스 피티와이 리미티드 | 비정질 약학적 조성물을 이용한 경피전달속도의 제어 |
| DE10305811A1 (de) * | 2003-02-12 | 2004-08-26 | Ethicon Gmbh | Chirurgisches Implantat |
| WO2005030175A1 (en) * | 2003-09-29 | 2005-04-07 | Novo Nordisk Femcare Ag | Hrt formulations |
| WO2005030176A1 (en) * | 2003-09-29 | 2005-04-07 | Novo Nordisk Femcare Ag | Improved stability of progestogen formulations |
| US8658201B2 (en) | 2004-01-30 | 2014-02-25 | Corium International, Inc. | Rapidly dissolving film for delivery of an active agent |
| WO2006017807A2 (en) | 2004-08-05 | 2006-02-16 | Corium International, Inc. | Adhesive composition |
| DE102004059880A1 (de) * | 2004-12-10 | 2006-06-14 | Grünenthal GmbH | Stabiles, hormonhaltiges (Zwischen-)Produkt |
| ES2607454T3 (es) | 2005-06-03 | 2017-03-31 | Acrux Dds Pty Ltd | Método y composición para el suministro transdérmico de testosterona |
| US20070065494A1 (en) * | 2005-08-03 | 2007-03-22 | Watson Laboratories, Inc. | Formulations and Methods for Enhancing the Transdermal Penetration of a Drug |
| US10137135B2 (en) * | 2005-08-15 | 2018-11-27 | Allergan Sales, Llc | Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith |
| FI3456329T3 (fi) | 2005-10-12 | 2025-02-27 | Besins Healthcare Lu Sarl | Parannettu testosteronigeeli ja käyttömenetelmä |
| US20070258935A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water dispersible films for delivery of active agents to the epidermis |
| US20070259029A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water-dispersible patch containing an active agent for dermal delivery |
| US20080057090A1 (en) * | 2006-09-01 | 2008-03-06 | Mcentire Edward Enns | Wrinkle masking film composition for skin |
| US7879942B2 (en) * | 2006-10-05 | 2011-02-01 | Eastman Chemical Company | Switchable adhesive article for attachment to skin and method of using the same |
| ES2643318T3 (es) * | 2006-10-24 | 2017-11-22 | Repros Therapeutics Inc. | Composiciones y métodos para suprimir la proliferación endometrial |
| IN2009KN02397A (pt) | 2007-01-11 | 2015-08-07 | Acrux Dds Pty Ltd | |
| US20080175877A1 (en) * | 2007-01-22 | 2008-07-24 | Isense Corporation | Adhesives with antiperspirant and/or anti-inflammatory additives |
| ES2820335T3 (es) | 2007-04-16 | 2021-04-20 | Corium Inc | Matrices de microagujas coladas con disolvente que contienen agente activo |
| JP4948267B2 (ja) * | 2007-05-25 | 2012-06-06 | 東芝機械株式会社 | シート・フィルム成形装置及びシート・フィルム成形方法 |
| US20090098191A1 (en) * | 2007-10-16 | 2009-04-16 | Anderson Christopher G | Use of bases to stabilize transdermal formulations |
| DE102008013701A1 (de) * | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit stabilisierter Membran |
| US20090285893A1 (en) * | 2008-05-19 | 2009-11-19 | The Procter & Gamble Company | Treatment of heart failure in women |
| AU2010204986B2 (en) | 2009-01-14 | 2016-06-02 | Corium International, Inc. | Transdermal administration of tamsulosin |
| CA2798145C (en) | 2010-05-04 | 2022-10-18 | Corium International, Inc. | Method and device for transdermal delivery of parathyroid hormone using a microprojection array |
| WO2012103015A2 (en) * | 2011-01-27 | 2012-08-02 | Csi Gmbh | Extended-release beta agonist/steroid transdermal patches and methods for using the same |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
| US9849095B2 (en) * | 2011-12-01 | 2017-12-26 | Teikoku Seiyaku Co., Ltd. | Ropinirole-containing adhesive patch |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| CN105073178B (zh) | 2012-12-21 | 2019-07-30 | 考里安国际公司 | 用于治疗剂递送的微阵列及其使用方法 |
| WO2014164314A1 (en) | 2013-03-12 | 2014-10-09 | Corium International, Inc. | Microprojection applicators |
| WO2014150293A1 (en) * | 2013-03-15 | 2014-09-25 | Corium International, Inc. | Microarray with polymer-free microstructures, methods of making, and methods of use |
| AU2014237357B2 (en) | 2013-03-15 | 2019-11-28 | Corium Pharma Solutions, Inc. | Multiple impact microprojection applicators and methods of use |
| BR112015022625B1 (pt) | 2013-03-15 | 2023-01-31 | Corium, Inc | Aparelho de microestrutura para entrega de agente terapêutico |
| USD749225S1 (en) | 2013-11-26 | 2016-02-09 | Acrux Dds Pty Ltd | Topical spreading applicator |
| USD750788S1 (en) | 2013-11-26 | 2016-03-01 | Acrux Dds Pty Ltd | Topical spreading applicator |
| US10206932B2 (en) | 2014-05-22 | 2019-02-19 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| KR20170040209A (ko) | 2014-07-29 | 2017-04-12 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 경피 크림 |
| US10624843B2 (en) | 2014-09-04 | 2020-04-21 | Corium, Inc. | Microstructure array, methods of making, and methods of use |
| WO2017004067A1 (en) | 2015-06-29 | 2017-01-05 | Corium International, Inc. | Microarray for delivery of therapeutic agent, methods of use, and methods of making |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| CN108773912B (zh) * | 2018-08-17 | 2021-06-08 | 南宁市黄陈生猪养殖场 | 一种畜禽养殖污水的菌剂处理工艺 |
| CN108996832B (zh) * | 2018-08-17 | 2021-05-07 | 南宁市黄陈生猪养殖场 | 一种利用菌剂处理工业废水的工艺 |
| JP7515582B2 (ja) | 2019-11-06 | 2024-07-12 | スマーテック トピカル，インコーポレイテッド | シクロオキシゲナーゼ阻害剤の局所配合剤およびその使用 |
| CN111067709B (zh) * | 2019-11-15 | 2022-05-13 | 惠州市浩明科技股份有限公司 | 医用胶带的制备方法及卷绕储存方法 |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3551554A (en) | 1968-08-16 | 1970-12-29 | Crown Zellerbach Corp | Enhancing tissue penetration of physiologically active agents with dmso |
| US3711606A (en) | 1970-09-02 | 1973-01-16 | Crown Zellerbach Corp | Enhancing tissue penetration of physiologically active steroidal agents with dmso |
| US3711602A (en) | 1970-10-30 | 1973-01-16 | Crown Zellerbach Corp | Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso |
| US3964482A (en) * | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
| CA1165240A (en) | 1980-07-09 | 1984-04-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
| US4557943A (en) | 1983-10-31 | 1985-12-10 | Advanced Semiconductor Materials America, Inc. | Metal-silicide deposition using plasma-enhanced chemical vapor deposition |
| US4954343A (en) * | 1986-03-29 | 1990-09-04 | Nitto Electric Industrial Co., Ltd. | Dermal pharmaceutical preparations |
| US5145682A (en) * | 1986-05-30 | 1992-09-08 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration |
| US4863970A (en) | 1986-11-14 | 1989-09-05 | Theratech, Inc. | Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols |
| JPS63132889A (ja) | 1986-11-21 | 1988-06-04 | Tanabe Seiyaku Co Ltd | キナゾリノン誘導体 |
| US5023084A (en) * | 1986-12-29 | 1991-06-11 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
| CH674618A5 (pt) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
| US4983395A (en) * | 1987-11-12 | 1991-01-08 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
| US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| AU622162B2 (en) * | 1988-04-22 | 1992-04-02 | Ciba-Geigy Ag | Transdermal monolith systems |
| US4829224A (en) | 1988-05-23 | 1989-05-09 | George Gandelman | Battery pack for cellular telephone |
| US5059426A (en) * | 1989-03-22 | 1991-10-22 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
| US5232703A (en) * | 1989-07-21 | 1993-08-03 | Izhak Blank | Estradiol compositions and methods for topical application |
| CA2065311C (en) * | 1989-09-08 | 2000-01-11 | Chia-Ming Chiang | Solid matrix system for transdermal drug delivery |
| US5252334A (en) * | 1989-09-08 | 1993-10-12 | Cygnus Therapeutic Systems | Solid matrix system for transdermal drug delivery |
| JP2849937B2 (ja) * | 1990-04-18 | 1999-01-27 | 日東電工株式会社 | 医療用貼付剤 |
| PT99338A (pt) * | 1990-10-29 | 1992-10-30 | Alza Corp | Processo para a preparacao de composicoes de farmacos anticoncepcionais administradas transdermicamente contendo uma mistura dum estrogeno e gestodeno e dispositivos para a sua administracao transdermica |
| US5122383A (en) * | 1991-05-17 | 1992-06-16 | Theratech, Inc. | Sorbitan esters as skin permeation enhancers |
| US5152997A (en) * | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
| JPH04342532A (ja) * | 1991-05-21 | 1992-11-30 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
| IL116539A (en) * | 1995-01-06 | 2002-02-10 | Noven Pharma | Preparations given through the skin of unstable anti-acid drugs |
| JP4032532B2 (ja) * | 1998-10-23 | 2008-01-16 | 日立化成工業株式会社 | 回路部材の実装方法 |
-
1995
- 1995-07-20 US US08/504,430 patent/US5780050A/en not_active Expired - Lifetime
-
1996
- 1996-06-21 AU AU62874/96A patent/AU710760B2/en not_active Ceased
- 1996-06-21 EP EP20100180180 patent/EP2305195B1/en not_active Expired - Lifetime
- 1996-06-21 MX MX9800545A patent/MX9800545A/es not_active IP Right Cessation
- 1996-06-21 WO PCT/US1996/010711 patent/WO1997003629A1/en not_active Ceased
- 1996-06-21 CN CNB2003101245811A patent/CN100446769C/zh not_active Expired - Fee Related
- 1996-06-21 CA CA002226425A patent/CA2226425C/en not_active Expired - Lifetime
- 1996-06-21 KR KR1019970709812A patent/KR100505171B1/ko not_active Expired - Fee Related
- 1996-06-21 JP JP50667897A patent/JP3422796B2/ja not_active Expired - Lifetime
- 1996-06-21 CN CNB961956941A patent/CN1137689C/zh not_active Expired - Fee Related
- 1996-06-21 DK DK10180180.1T patent/DK2305195T3/en active
- 1996-06-21 EP EP96921735.5A patent/EP0876131B1/en not_active Expired - Lifetime
- 1996-06-21 BR BRPI9609738-8A patent/BR9609738B1/pt not_active IP Right Cessation
- 1996-06-21 DK DK96921735.5T patent/DK0876131T3/da active
- 1996-07-02 ZA ZA965607A patent/ZA965607B/xx unknown
-
2000
- 2000-08-22 JP JP2000250920A patent/JP4344076B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1191475A (zh) | 1998-08-26 |
| CN100446769C (zh) | 2008-12-31 |
| US5780050A (en) | 1998-07-14 |
| CN1137689C (zh) | 2004-02-11 |
| AU6287496A (en) | 1997-02-18 |
| EP2305195B1 (en) | 2015-04-22 |
| AU710760B2 (en) | 1999-09-30 |
| CA2226425C (en) | 2009-08-18 |
| JP4344076B2 (ja) | 2009-10-14 |
| JP2001072580A (ja) | 2001-03-21 |
| KR100505171B1 (ko) | 2005-11-22 |
| DK2305195T3 (en) | 2015-06-29 |
| HK1066724A1 (zh) | 2005-04-01 |
| JP3422796B2 (ja) | 2003-06-30 |
| DK0876131T3 (da) | 2014-11-24 |
| BR9609738B1 (pt) | 2009-05-05 |
| CA2226425A1 (en) | 1997-02-06 |
| JPH10510548A (ja) | 1998-10-13 |
| EP0876131A4 (pt) | 1998-12-02 |
| EP2305195A1 (en) | 2011-04-06 |
| MX9800545A (es) | 1998-04-30 |
| CN1509718A (zh) | 2004-07-07 |
| WO1997003629A1 (en) | 1997-02-06 |
| EP0876131A1 (en) | 1998-11-11 |
| KR19990028496A (ko) | 1999-04-15 |
| HK1017983A1 (en) | 1999-12-10 |
| EP0876131B1 (en) | 2014-08-13 |
| ZA965607B (en) | 1997-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9609738A (pt) | Composições para aplicação de droga para estabilidade melhorada de esteróides | |
| PT812195E (pt) | Composicao farmaceutica para compostos de piperidinoalcanol | |
| IS4706A (is) | Lyfjasamsetningar | |
| NO962606L (no) | Farmasöytisk sammensetning | |
| PT998272E (pt) | Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol | |
| FI20071025L (fi) | Farmaseuttisia koostumuksia | |
| CY2005007I1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη | |
| ID18352A (id) | Komposisi-komposisi farmasi | |
| NO965444D0 (no) | Triterpen-derivat samt medikamentell sammensetning omfattende dette | |
| BR9507768A (pt) | Composição farmacêutica | |
| FI973229A7 (fi) | Uusi farmaseuttinen koostumus | |
| LV11727A (lv) | Farmaceitiska kompozicija | |
| EE9900206A (et) | N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid | |
| IS2515B (is) | Lyfjasamsetningar | |
| PT941100E (pt) | Composicoes farmaceuticas | |
| FI973280A0 (fi) | Farmaseuttinen koostumus | |
| ITMI942166A0 (it) | Composizioni farmaceutiche miorilassanti | |
| EE200000330A (et) | Farmatseutilised kompositsioonid | |
| FI973230A0 (fi) | Uusi farmaseuttinen formulaatio | |
| BR9605777A (pt) | Composição farmacêutica | |
| FI954050A7 (fi) | Lääkekoostumuksia | |
| FI962738A0 (fi) | Farmaseuttiset koostumukset | |
| NO964309D0 (no) | Farmasöytisk sammensetning | |
| NO994436L (no) | Farmasöytiske sammensetninger | |
| KR960016881A (ko) | 제약 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: WATSON LABORATORIES, INC. - UTAH (US) Free format text: ALTERADO DE: THERATECH, INC. |
|
| B25D | Requested change of name of applicant approved |
Owner name: WATSON LABORATORIES, INC. (US) Free format text: ALTERADO DE: WATSON LABORATORIES, INC. - UTAH |
|
| B25A | Requested transfer of rights approved |
Owner name: WATSON PHARMACEUTICALS, INC. (US) Free format text: TRANSFERIDO DE: WATSON LABORATORIES, INC. |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/07/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B24C | Patent annual fee: request for for restoration |
Free format text: REFERENTE AS 15A E 16A ANUIDADES. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AO DESPACHO 24.3 PUBLICADO NA RPI 2188 DE 11/12/2012. |